Peptide of the Month: MOTS-C
Continuing our series on peptides, this month Dr. Dominique Fradin-Read introduces MOTS-C, a fascinating peptide that is naturally encoded within the mitochondrial genome.
MOTS-C a “Mitochondria Encoded Peptide”
Mitochondria are small organelles found in nearly every cell of the body. Often referred to as the cell’s “powerhouse,” they play a critical role in energy production and metabolic regulation.
Unlike other cellular structures, mitochondria possess their own DNA, known as mitochondrial DNA (mtDNA). This genetic material can encode bioactive peptides that help regulate a variety of physiological functions throughout the body.
One of these peptides a 16 amino- acid chain called MOTS-C was discovered in 2015; it plays an important role as a signaling molecule involved in energy production, insulin sensitivity, and metabolic regulation. Think of MOTS-C as a messenger from the mitochondria that tells cells to become more efficient at producing and using energy. It helps cells absorb fuel, activate energy-producing pathways, and adapt to increased energy demands, which may support overall metabolic health.
Retrograde Action of MOTS-C to the Nucleus
One of the most unique features of MOTS-C is its ability to participate in mitochondrial-to-nuclear communication, often called retrograde signaling.
Under conditions of metabolic stress—such as exercise, fasting, oxidative stress, fatigue or nutrient deprivation--, MOTS-C can move from the mitochondria into the nucleus of the cell. Once in the nucleus, it influences the expression of genes involved in metabolism, stress resistance, and cellular adaptation.
This process is significant because it allows the mitochondria to communicate their energetic status directly to the nucleus and switch on genes that improve the cell's ability to produce energy, manage stress, and maintain metabolic health.
MOTS-C and Fatigue-Energy Support
As we age, mitochondrial function often declines, leading to reduced energy production, impaired metabolic health, and increased fatigue. By helping cells optimize fuel utilization and adapt to metabolic stress, MOTS-C has emerged as an important molecule in the study of energy production. plays a key role in regulating how the body produces, uses, and conserves energy. Rather than directly generating energy itself, MOTS-C acts as a signaling molecule that helps cells become more efficient at utilizing available fuel sources.
MOTS-C supports energy production through various mechanisms
Increase in Glucose Utilization
The peptide enhances the uptake and use of glucose by cells, providing a readily available source of energy for cellular processes and physical activity.Activation of the enzyme AMPK
It activates AMPK (activated protein kinase) a central regulator of cellular energy balance. When energy levels are low, AMPK stimulates pathways that generate energy and suppresses processes that consume it.Support of metabolism flexibility
It helps the body switch between burning carbohydrates and fats depending on energy demands. This flexibility allows cells to maintain energy production under varying conditions.
MOTS-C and Metabolism
MOTS-C improves metabolic homeostasis and improves insulin resistance.
The peptide has gained attention for its potential role in weight management because of its effects on metabolism, energy utilization, and insulin sensitivity. While it is not a weight-loss drug, research suggests that it may help support metabolic processes that influence body weight and body composition.
MOTS-C helps cells respond more effectively to insulin, allowing glucose to be used for energy rather than remaining in the bloodstream or being stored as fat. Improved insulin sensitivity is associated with better metabolic health and weight regulation.
Studies suggest that MOTS-C may enhance the body's ability to use stored fat as a fuel source, particularly during periods of increased energy demand such as exercise.
by activating cellular energy pathways, including AMPK, MOTS-C helps cells optimize how they use nutrients. This may support a healthier metabolic rate and improved energy balance.
Mitochondrial function and metabolic efficiency often decrease with age. MOTS-C may help maintain metabolic flexibility and energy utilization, factors that can influence body weight over time.
Until now MOTS-C has been viewed as a metabolic optimization peptide rather than a direct weight-loss treatment. Its primary actions involve improving how the body uses energy, glucose, and fat. Any effects on body weight are likely secondary to these improvements in metabolic function.
MOTS.C and Brown Adipose Tissue
One of the emerging areas of MOTS-C research is its relationship with brown adipose tissue (BAT), commonly known as brown fat. Brown adipose tissue helps regulate body temperature and energy expenditure. Its high concentration of mitochondria contains a protein called uncoupling protein 1 (UCP1), which allows energy to be released as heat rather than stored.
Unlike white fat, which primarily stores energy, brown fat burns calories to produce heat through a process called thermogenesis. Preclinical research suggests that MOTS-C may help stimulate the development of brown fat adipocytes—cells within white fat that acquire brown fat-like characteristics and increased thermogenic capacity. If MOTS-C can enhance brown fat activity or promote the browning of white fat, it could potentially contribute to increase energy expenditures and reduce fat accumulation offering a healthier body composition.
Anti-I\inflammatory and Immune System Effects
MOTS-C is increasingly recognized not only as a regulator of metabolism but also as an important mediator of inflammation and immune function. Because metabolism and immunity are closely interconnected, MOTS-C may help coordinate the body's response to metabolic stress, cellular damage, and inflammation.
Chronic low-grade inflammation is a hallmark of many age-related and metabolic diseases, including obesity, insulin resistance, type 2 diabetes, and cardiovascular disease.
Research suggests that MOTS-C may help reduce excessive inflammation by:
Decreasing the production of pro-inflammatory molecules that contribute to chronic tissue damage such as NF-κB, TNF-α, IL-6, IL-1β
Reducing oxidative stress, a major trigger of inflammation and cellular aging.
Improving mitochondrial function, which can help prevent the release of inflammatory signals from stressed or damaged cells.
Activating protective cellular pathways (AMPK, SIRT1, m-TOR) that enhance resilience to metabolic and environmental stressors.
Through these actions, MOTS-C may help maintain a healthier inflammatory balance within the body.
The immune system requires large amounts of energy to function effectively. By regulating cellular metabolism, MOTS-C may influence how immune cells respond to infection, injury, and stress. regulates T cell metabolism and immune responses. By directly interacting with T cell pathways, it promotes protective regulatory T cells (Treg), suppresses inflammatory Th1 cells, and has been shown to prevent autoimmune damage in animal models of Type 1 Diabetes.
MOTS-C in Exercise and Aging
MOTS-C sits at the intersection of metabolism, physical activity, and aging because it is a mitochondrial signal that helps cells adapt to energy demand. Since both exercise capacity and mitochondrial function decline with age, MOTS-C is being studied as a molecule that may help connect these processes.
During exercise, endogenous MOTS-C production is activated in mitochondria as part of the body’s response to increased energy demand. This supports improved glucose utilization, enhanced fat oxidation, greater mitochondrial efficiency, and increased endurance—helping explain many of the metabolic benefits of physical activity. The type of exercise may also matter, as regular moderate-intensity running has been shown to strongly increase MOTS-C expression, whereas a single bout of high-intensity exercise to exhaustion does not produce the same effect.
With aging, mitochondrial function gradually declines, leading to reduced energy production, increased fatigue, and impaired metabolic health. MOTS-C signaling may also become less efficient with age, potentially contributing to these changes. Regular exercise appears to help maintain or reactivate this pathway, supporting healthier metabolic function over time.
Conversely, experimental studies in mice show that MOTS-C administration can improve exercise performance, including longer running time, increased endurance, and higher maximal speed. These effects are thought to occur in part through improved skeletal muscle function and enhanced metabolic flexibility. Because of its potential to influence physical performance, MOTS-C has also attracted attention from anti-doping authorities, and methods have been proposed to detect it in plasma to prevent misuse in sport.
Overall, MOTS-C acts as a key link between exercise and aging by helping cells adapt to energy demands. It supports metabolic flexibility and may help explain some of the anti-aging and health-promoting effects of regular physical activity, although most evidence to date comes from preclinical research.
A Potential Benefit for Postmenopausal Women
Benefits for weight:
Postmenopausal women are known to exhibit physiological changes, including weight gain, changes in the distribution of adipose tissue, and a decrease in insulin secretion and sensitivity. Studies show that MOTS-c treatment prevents postmenopausal obesity and insulin resistance
Benefits for bones:
MOTS-c treatment has been shown in various studies to significantly alleviate bone loss and slow the progression of osteoporosis. In agreement with these preclinical studies, postmenopausal women are at increased risk of obesity, insulin resistance and osteoporosis, Currently, the main treatment for postmenopausal is hormone therapy. The discovery of MOTS-c may be a promising adjunctive therapy for postmenopausal women.
Conclusion
MOTS-C is a scientifically interesting mitochondrial peptide with encouraging early research suggesting potential metabolic and aging-related benefits. Most of the evidence for MOTS-C comes from laboratory and early clinical research; therefore it remains an experimental compound. Scientists are still studying its long-term effects, optimal dosing, and potential therapeutic applications in humans.